Susquehanna International Group’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-18,318
| Closed | -$608K | – | 14173 |
|
|
2022
Q4 | $608K | Buy |
18,318
+4,819
| +36% | +$155K | ﹤0.01% | 7352 |
|
|
2022
Q3 | $426K | Buy |
+13,499
| New | +$437K | ﹤0.01% | 8900 |
|
|
2022
Q1 | – | Sell |
-24,891
| Closed | -$592K | – | 14387 |
|
|
2021
Q4 | $508K | Sell |
24,891
-48,279
| -66% | -$926K | ﹤0.01% | 9170 |
|
|
2021
Q3 | $1.41M | Sell |
73,170
-66,266
| -48% | -$1.32M | ﹤0.01% | 6659 |
|
|
2021
Q2 | $3.09M | Buy |
+139,436
| New | +$2.96M | ﹤0.01% | 4954 |
|
|
2021
Q1 | – | Sell |
-20,085
| Closed | -$478K | – | 13047 |
|
|
2020
Q4 | $375K | Sell |
20,085
-44,675
| -69% | -$834K | ﹤0.01% | 8853 |
|
|
2020
Q3 | $1.1M | Sell |
64,760
-53,120
| -45% | -$1.03M | ﹤0.01% | 5870 |
|
|
2020
Q2 | $2.75M | Buy |
117,880
+29,018
| +33% | +$421K | ﹤0.01% | 3955 |
|
|
2020
Q1 | $746K | Buy |
88,862
+57,138
| +180% | +$481K | ﹤0.01% | 6041 |
|
|
2019
Q4 | $310K | Buy |
31,724
+6,053
| +24% | +$56.8K | ﹤0.01% | 7950 |
|
|
2019
Q3 | $244K | Sell |
25,671
-5,066
| -16% | -$53.4K | ﹤0.01% | 8718 |
|
|
2019
Q2 | $365K | Buy |
+30,737
| New | +$370K | ﹤0.01% | 7920 |
|
|
2018
Q1 | – | Sell |
-52,361
| Closed | -$775K | – | 10448 |
|
|
2017
Q4 | $733K | Buy |
52,361
+23,361
| +81% | +$342K | ﹤0.01% | 5863 |
|
|
2017
Q3 | $415K | Buy |
+29,000
| New | +$414K | ﹤0.01% | 6843 |
|
|
2017
Q1 | – | Sell |
-65,399
| Closed | -$915K | – | 10275 |
|
|
2016
Q4 | $1.16M | Sell |
65,399
-8,742
| -12% | -$154K | ﹤0.01% | 5211 |
|
|
2016
Q3 | $1.43M | Sell |
74,141
-12,920
| -15% | -$253K | ﹤0.01% | 4141 |
|
|
2016
Q2 | $1.7M | Sell |
87,061
-26,380
| -23% | -$517K | ﹤0.01% | 3868 |
|
|
2016
Q1 | $2.34M | Buy |
113,441
+20,641
| +22% | +$407K | ﹤0.01% | 3469 |
|
|
2015
Q4 | $1.9M | Buy |
+92,800
| New | +$1.78M | ﹤0.01% | 4133 |
|
|
2015
Q3 | – | Sell |
-28,862
| Closed | -$527K | – | 10380 |
|
|
2015
Q2 | $538K | Buy |
+28,862
| New | +$535K | ﹤0.01% | 7494 |
|
|
2015
Q1 | – | Sell |
-82,268
| Closed | -$1.52M | – | 10090 |
|
|
2014
Q4 | $1.35M | Buy |
82,268
+47,835
| +139% | +$821K | ﹤0.01% | 5259 |
|
|
2014
Q3 | $609K | Buy |
34,433
+11,054
| +47% | +$217K | ﹤0.01% | 6849 |
|
|
2014
Q2 | $483K | Buy |
+23,379
| New | +$480K | ﹤0.01% | 7545 |
|
|
2014
Q1 | – | Sell |
-42,211
| Closed | -$968K | – | 9576 |
|
|
2013
Q4 | $1.12M | Buy |
+42,211
| New | +$1.04M | ﹤0.01% | 5315 |
|
Other funds holding VIVO
Susquehanna International Group's VIVO Position: Q1 2023 in Review
Susquehanna International Group sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 18,318 shares — an estimated $608K sold.
Susquehanna International Group first reported a position in VIVO in Q4 2013 and held it in 24 quarters. The position peaked at $3.09M in Q2 2021. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- Susquehanna International Group reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- Susquehanna International Group sold 18,318 Meridian Bioscience Inc shares in Q1 2023, an estimated $608K.
- Susquehanna International Group first reported a position in Meridian Bioscience Inc in Q4 2013 and held it in 24 quarters.
- Susquehanna International Group's Meridian Bioscience Inc position peaked at $3.09M in Q2 2021.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.